JPMorgan Chase & Co’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,921
| Closed | -$17.8K | – | 6453 |
|
|
2024
Q2 | $17.8K | Sell |
6,921
-4,289
| -38% | -$11K | ﹤0.01% | 5170 |
|
|
2024
Q1 | $32.7K | Sell |
11,210
-17,556
| -61% | -$51.3K | ﹤0.01% | 5104 |
|
|
2023
Q4 | $66.4K | Sell |
28,766
-17,250
| -37% | -$39.8K | ﹤0.01% | 4922 |
|
|
2023
Q3 | $120K | Sell |
46,016
-7,835
| -15% | -$20.4K | ﹤0.01% | 4500 |
|
|
2023
Q2 | $193K | Sell |
53,851
-120,271
| -69% | -$431K | ﹤0.01% | 4293 |
|
|
2023
Q1 | $379K | Sell |
174,122
-230,495
| -57% | -$502K | ﹤0.01% | 3970 |
|
|
2022
Q4 | $4.87M | Buy |
404,617
+120,014
| +42% | +$1.44M | ﹤0.01% | 2394 |
|
|
2022
Q3 | $1.84M | Sell |
284,603
-51,946
| -15% | -$337K | ﹤0.01% | 2972 |
|
|
2022
Q2 | $1.54M | Buy |
336,549
+318,801
| +1,796% | +$1.46M | ﹤0.01% | 3175 |
|
|
2022
Q1 | $153K | Sell |
17,748
-17,209
| -49% | -$148K | ﹤0.01% | 4566 |
|
|
2021
Q4 | $499K | Buy |
34,957
+23,749
| +212% | +$339K | ﹤0.01% | 4057 |
|
|
2021
Q3 | $246K | Buy |
11,208
+952
| +9% | +$20.9K | ﹤0.01% | 4314 |
|
|
2021
Q2 | $137K | Buy |
+10,256
| New | +$137K | ﹤0.01% | 4661 |
|
|
2020
Q3 | – | Sell |
-13
| Closed | – | – | 4945 |
|
|
2020
Q2 | $0 | Sell |
13
-2,987
| -100% | – | ﹤0.01% | 4881 |
|
|
2020
Q1 | $9K | Buy |
+3,000
| New | +$9K | ﹤0.01% | 4466 |
|
|
2018
Q1 | – | Sell |
-1,700
| Closed | -$15K | – | 4756 |
|
|
2017
Q4 | $15K | Buy |
1,700
+815
| +92% | +$7.19K | ﹤0.01% | 4438 |
|
|
2017
Q3 | $9K | Buy |
+885
| New | +$9K | ﹤0.01% | 4064 |
|
|
2016
Q3 | – | Sell |
-10
| Closed | – | – | 4197 |
|
|
2016
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4319 |
|